Domac Fusun M, Misirli Handan
Department of Neurology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey. Tel. +90 (216) 4556758. Fax. +90 (262) 7511267. E-mail:
Neurosciences (Riyadh). 2008 Apr;13(2):136-41.
To investigate the crucial role of interleukin 8 (IL-8) as an inflammatory marker in infarct evolution, and course of the disease.
The study included 76 patients that were admitted to Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey between September 2001 and June 2002 with an initial diagnosis of acute ischemic stroke, and 28 control subjects with a corresponding mean age. The serum IL-8 levels obtained within 24 hours of the stroke were assessed by the enzyme-linked immunoabsorbent assay method. The patients were divided into 4 groups according to the extent, and localization of the ischemic lesions. Prognosis was evaluated by modified Rankin Scale.
In comparison between patients and control groups, there was a statistically significant difference in (p<0.001) IL-8, and neutrophil (net) levels (p=0.000). The serum IL-8 levels were associated with the extent of the lesion (p<0.01). Though the serum IL-8 levels were significantly higher in the dependent group (p<0.05), there was no significant difference between net levels, and prognosis (p>0.05). There was also no significant difference according to age, gender, and etiology between IL-8 and net levels.
The high serum IL-8 levels are associated with prognosis. The development of new neuroprotective treatments aimed to prevent neutrophil-mediated-inflammation induced by IL-8 is critical in the treatment of stroke, and prevention of clinical worsening.
探讨白细胞介素8(IL-8)作为炎症标志物在梗死演变及疾病进程中的关键作用。
该研究纳入了2001年9月至2002年6月期间最初诊断为急性缺血性卒中并入住土耳其伊斯坦布尔海达尔帕萨努穆内培训和研究医院的76例患者,以及28例年龄均值相当的对照受试者。采用酶联免疫吸附测定法评估卒中后24小时内获得的血清IL-8水平。根据缺血性病变的范围和定位将患者分为4组。采用改良Rankin量表评估预后。
患者组与对照组相比,IL-8水平及中性粒细胞(净)水平存在统计学显著差异(p<0.001)(p=0.000)。血清IL-8水平与病变范围相关(p<0.01)。虽然依赖组的血清IL-8水平显著更高(p<0.05),但净水平与预后之间无显著差异(p>0.05)。IL-8水平与净水平在年龄、性别和病因方面也无显著差异。
血清IL-8水平升高与预后相关。开发旨在预防由IL-8诱导的中性粒细胞介导的炎症的新神经保护治疗方法对于卒中治疗及预防临床恶化至关重要。